HU9301369D0 - Self-supporting sequence replicating nucleinic acid having two enzymes - Google Patents

Self-supporting sequence replicating nucleinic acid having two enzymes

Info

Publication number
HU9301369D0
HU9301369D0 HU931369A HUP9301369A HU9301369D0 HU 9301369 D0 HU9301369 D0 HU 9301369D0 HU 931369 A HU931369 A HU 931369A HU P9301369 A HUP9301369 A HU P9301369A HU 9301369 D0 HU9301369 D0 HU 9301369D0
Authority
HU
Hungary
Prior art keywords
enzymes
self
sequence replicating
supporting sequence
nucleinic acid
Prior art date
Application number
HU931369A
Other languages
Hungarian (hu)
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
John Christopher Guatelli
Kristina Marie Whitfield
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of HU9301369D0 publication Critical patent/HU9301369D0/en
Publication of HUT69772A publication Critical patent/HUT69772A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9301369A 1990-11-13 1991-11-13 Nucletic acid amplification by two-enzyme, self-sustrained sequence replication HUT69772A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13

Publications (2)

Publication Number Publication Date
HU9301369D0 true HU9301369D0 (en) 1993-10-28
HUT69772A HUT69772A (en) 1995-09-28

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9301369A HUT69772A (en) 1990-11-13 1991-11-13 Nucletic acid amplification by two-enzyme, self-sustrained sequence replication

Country Status (13)

Country Link
EP (1) EP0572417A4 (en)
JP (1) JPH06502767A (en)
AU (1) AU9131591A (en)
CA (1) CA2096013A1 (en)
FI (1) FI932144A (en)
HU (1) HUT69772A (en)
IE (1) IE913930A1 (en)
IL (1) IL100040A (en)
NO (1) NO931709L (en)
NZ (1) NZ240574A (en)
PT (1) PT99500A (en)
WO (1) WO1992008800A1 (en)
ZA (1) ZA918965B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628076A1 (en) * 1992-11-19 1994-12-14 GINGERAS, Thomas R. PRODUCTION OF MONOCLONAL RECOMBINANT ANTIBODIES WITHOUT THE USE OF HYBRIDOMAS BY $i(IN VITRO) SPLEEN FRAGMENT CULTURE COMBINED WITH ISOTHERMAL SELF-SUSTAINED SEQUENCE REPLICATION OF RNA
EP0682121B1 (en) * 1993-12-01 2002-08-28 Toyo Boseki Kabushiki Kaisha Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (en) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd Reverse transcriptase-stabilized composition
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (en) * 1999-07-16 2001-02-06 Shimadzu Corp Amplification of rna
WO2002012263A1 (en) 2000-08-03 2002-02-14 Roche Diagnostics Gmbh Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
US6780588B2 (en) 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
WO2003057910A2 (en) 2002-01-08 2003-07-17 Roche Diagnostics Gmbh Use of silica material in an amplification reaction
US7122314B2 (en) 2002-01-30 2006-10-17 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (en) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Improved procedures for the synthesis of nucleic acids
DE602004009038T3 (en) 2003-01-29 2015-06-25 Roche Diagnostics Gmbh Improved bisulfite treatment method
JP2004357502A (en) * 2003-05-30 2004-12-24 Olympus Corp Method for processing information using nucleic acid molecule
WO2006006722A1 (en) 2004-07-13 2006-01-19 Takeda Pharmaceutical Company Limited Method of controlling cell functions
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
AU2008283902B2 (en) 2007-08-06 2014-03-13 Orion Genomics Llc Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
AU2008318316B2 (en) 2007-11-01 2015-08-06 University Of Iowa Research Foundation RCA locus analysis to assess susceptibility to AMD and MPGNII
EP2396429B1 (en) 2009-02-11 2015-05-27 Orion Genomics, LLC Combinations of polymorphisms for determining allele-specific expression of igf2
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
US20130143214A1 (en) 2010-06-04 2013-06-06 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US20140004510A1 (en) 2010-09-24 2014-01-02 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
US9458484B2 (en) 2010-10-22 2016-10-04 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
EP2751280B1 (en) 2011-08-31 2016-06-29 F.Hoffmann-La Roche Ag Method for predicting risk of hypertension associated with anti-angiogenesis therapy
WO2013030167A1 (en) 2011-08-31 2013-03-07 F. Hoffmann-La Roche Ag Responsiveness to angiogenesis inhibitors
KR20140064971A (en) 2011-09-19 2014-05-28 제넨테크, 인크. Combination treatments comprising c-met antagonists and b-raf antagonists
US20140303008A1 (en) 2011-10-21 2014-10-09 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
EP2783015A1 (en) 2011-11-23 2014-10-01 F.Hoffmann-La Roche Ag Responsiveness to angiogenesis inhibitors
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
US20160115541A1 (en) 2013-05-29 2016-04-28 Chronix Biomedical Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
KR20160138494A (en) 2014-03-31 2016-12-05 데비오팜 인터네셔날 에스 에이 Fgfr fusions
US20160168640A1 (en) 2014-11-10 2016-06-16 Genentech, Inc. Therapeutic and diagnostic methods for il-33-mediated disorders
ES2961374T3 (en) 2015-04-24 2024-03-11 Atila Biosystems Incorporated Amplification with primers of limited nucleotide composition
PT3640345T (en) 2015-08-17 2021-12-29 Kura Oncology Inc Methods of treating cancer patients with farnesyl transferase inhibitors
US20190119758A1 (en) 2016-04-22 2019-04-25 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
DK3534885T3 (en) 2016-11-03 2021-04-12 Kura Oncology Inc FARNESYLTRANSFERASE INHIBITORS FOR USE IN CANCER OF CANCER
EP3432883B1 (en) 2017-02-21 2021-07-28 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US10137121B2 (en) 2017-02-21 2018-11-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
MY200746A (en) 2017-08-07 2024-01-13 Kura Oncology Inc Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
KR20230142806A (en) 2018-02-09 2023-10-11 제넨테크, 인크. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
CA3117968A1 (en) 2018-11-01 2020-05-07 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220142983A1 (en) 2019-03-01 2022-05-12 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CN113795253A (en) 2019-03-29 2021-12-14 库拉肿瘤学公司 Method of treating squamous cell carcinoma with farnesyl transferase inhibitors
TW202102218A (en) 2019-04-01 2021-01-16 美商庫拉腫瘤技術股份有限公司 Methods of treating cancer with farnesyltransferase inhibitors
US20220305001A1 (en) 2019-05-02 2022-09-29 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
US20230110203A1 (en) 2020-03-13 2023-04-13 Medimmune Limited Therapeutic methods for the treatment of subjects with risk alelles in il33
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
ZA899593B (en) * 1988-12-16 1990-09-26 Siska Diagnostics Inc Self-sustained,sequence replication system
ATE282716T1 (en) * 1989-07-11 2004-12-15 Gen Probe Inc METHOD FOR AMPLIFICATION OF NUCLEIC ACID SEQUENCES

Also Published As

Publication number Publication date
WO1992008800A1 (en) 1992-05-29
IL100040A (en) 1995-12-31
FI932144A0 (en) 1993-05-12
NO931709D0 (en) 1993-05-11
JPH06502767A (en) 1994-03-31
PT99500A (en) 1992-10-30
EP0572417A1 (en) 1993-12-08
ZA918965B (en) 1992-08-26
IL100040A0 (en) 1992-08-18
IE913930A1 (en) 1992-06-17
NO931709L (en) 1993-07-12
EP0572417A4 (en) 1994-11-23
NZ240574A (en) 1994-10-26
AU9131591A (en) 1992-06-11
FI932144A (en) 1993-05-12
CA2096013A1 (en) 1992-05-14
HUT69772A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
HU9301369D0 (en) Self-supporting sequence replicating nucleinic acid having two enzymes
GB8706739D0 (en) Foldable fermenter
EP0315450A3 (en) Pellicle
GB2236778B (en) Keystone set
GB9004161D0 (en) Colourant
GB2209507B (en) Coupling
GB8719298D0 (en) Coupling
AU1288788A (en) Expansion peg
EP0468352A3 (en) Novel nucleic acid derivatives
GB2207932B (en) Structural members
GB2227018B (en) Piperazinylalkylcarboxylic acid adamantylamides
EP0423991A3 (en) 2-trifluoromethyl-4-hydroxybenzoic acid
GB2250794B (en) Connectors for structural members
GB8812842D0 (en) Stage system
IE900943L (en) Thienylacetic acid
GB8709441D0 (en) Tubes
GB8719597D0 (en) Stage system
PL264242A1 (en) Exchanger
CS109687A3 (en) General-purpose collapsible system for exhibition aims
GB9017176D0 (en) Anastomosis system
IE901958L (en) Enzymes
GB8718757D0 (en) Gas exchanges
BG52084B2 (en) Immunostimulating agent
AU100432S (en) Bookshelf
ZA877563B (en) Couplings

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee